Excelsior Sciences is based in New York. It has raised $95M in total funding. Latest round: Series A.
Excelsior Sciences is based in New York. Excelsior Sciences has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Excelsior Sciences runs through 2025; nothing later has been disclosed. Investors on record include Deerfield Management, Khosla Ventures, Sofinnova Partners, Cornucopian Capital, Eli Lilly and Company, Illinois Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Excelsior Sciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026